ArticlePharmacoEconomics - open2026

A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.

Divya Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.